Form Type: 4

SEC EDGAR Link
Acccession Number:0001209191-20-016942
Date:2020-03-04
Issuer: CARA THERAPEUTICS, INC. (CARA)
Original Submission Date:

Reporting Person:

IVES JEFFREY L.
C/O CARA THERAPEUTICS, INC.,
4 STAMFORD PLAZA, 107 ELM STREET STAMFORD, CT 06902

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-03-04 M 2,500 a $9.94 8,500 direct
COMMON STOCK 2020-03-04 S 2,500 d $16.00 6,000 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 9.94 2020-03-04 deemed execution date M 2,500 (d) 2025-06-08 common stock 2,500 $9.94 6,000 direct
Footnotes
IDfootnote
f1 this exercise and subsequent sale was effected pursuant to a rule 10b5-1 sales plan adopted by the reporting person on march 15, 2019.
f2 immediately exercisable.

Elevate your investments